Sunesis Pharmaceuticals Announces Presentations of VALOR Data at the 20th Congress of the European Hematology Association

By: via Benzinga
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that two poster presentations describing results from the VALOR trial will ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.